Pimozide Powder
NDC Package 66577-017-01
Package Information
Pimozide powders is a medication used to reduce uncontrolled movements (motor tics) or outbursts of words/sounds (vocal tics) caused by Tourette syndrome. This formulation utilizes a powder delivery system. Marketed by Vasudha Pharma Chem Limited, this product is identified by NDC 66577-017.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 66577 - Vasudha Pharma Chem Limited
- 66577-017 -
- 66577-017-01 - 25 kg in 1 DRUM
- 66577-017 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 66577-017-01 identifies a specific commercial package of 25 kg in 1 drum of Pimozide (UNFINISHED drug), a bulk ingredient labeled by Vasudha Pharma Chem Limited. This powder is formulated for use and contains pimozide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Vasudha Pharma Chem Limited on July 31, 1984. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to reduce uncontrolled movements (motor tics) or outbursts of words/sounds (vocal tics) caused by Tourette syndrome. Pimozide is a medication that works by decreasing the activity of a natural substance (dopamine) in the brain. Pimozide should not be used for mild symptoms. It should only be used if symptoms cause severe problems in everyday life and other medicines or treatments have not been effective.
How is this Vasudha Pharma Chem Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 66577001701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.